Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Sponsors
/ Nihon Pharmaceutical Co., Ltd
Nihon Pharmaceutical Co., Ltd
Industry · 19 registered clinical trials.
Status
Trial
Phase
Started
Unknown
Phase III Clinical Study of NPB-01 in Patients With Autoimmune Encephalitis
Autoimmune Encephalitis
Phase 3
2022-03-03
Completed
Study of NPO-13 During Colonoscopy
Bowel Disease
Phase 2
2019-08-26
Completed
Study of NPF-08 in Patients Who Receive Colonoscopy
Patients Who Receive Colonoscopy
Phase 3
2019-01-05
Completed
Phase I/II Clinical Trial of NPF-08 in Healthy Volunteers
Healthy Volunteers
Phase 1 / Phase 2
2017-10-06
Completed
Study of NPO-11 in Patients Undergoing Gastrointestinal Endoscopy
Patients Undergoing Gastrointestinal Endoscopy
Phase 3
2017-08-21
Completed
Phase Ⅱ Dose Response Study of NPO-13 in Patients Undergoing Total Colonoscopy
Bowel Disease
Phase 2
2014-10-01
Completed
Phase III Clinical Trial of NPB-01 in Patients With Guillain-Barré Syndrome
Guillain-Barré Syndrome
Phase 3
2014-10-01
Completed
Placebo-controlled Study of NPB-06 in Patients With Portal Vein Thrombosis
Portal Vein Thrombosis
Phase 3
2014-09-01
Completed
Phase II Clinical Trial of NPB-01 in Patients With Anti-aquaporin 4 Antibody Positive Neuromyelitis Optica Spe
Neuromyelitis Optica Spectrum Disorder
Phase 2
2013-05-01
Completed
Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Poly
Chronic Inflammatory Demyelinating Polyneuropathy
Phase 3
2013-04-01
Completed
Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Multifocal Motor Neuropathy.
Multifocal Motor Neuropathy
Phase 3
2013-04-01
Completed
Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unres
Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis
Phase 3
2012-10-01
Completed
Phase III Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy
Gastric Cancer
Phase 3
2011-09-01
Completed
Phase III Open-labeled Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy
Gastric Cancer, Colon Nos Polypectomy Tubular Adenoma, Gastric Adenoma
Phase 3
2011-09-01
Completed
Phase III Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids
Bullous Pemphigoid
Phase 3
2011-08-01
Completed
Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids.
Bullous Pemphigoid
Phase 2
2008-11-01
Completed
Phase III General Clinical Study of NPO-11 in Patients Undergoing Gastric Endoscopy
Stomach Diseases
Phase 3
2008-09-01
Completed
Phase III Controlled Clinical Study of NPO-11 in Patients Undergoing Gastric Endoscopy
Patients Undergoing Gastric Endoscopy
Phase 3
2008-09-01
Completed
Exploratory Study of Additional Use of Scopolamine Butylbromide, Glucagon or NPO-11 Following Single Dose of N
Healthy
Phase 3
2008-08-01